| Predicted Trait | |
| Reported Trait | Colorectal cancer | 
| Mapped Trait(s) | colorectal cancer (MONDO_0005575) | 
| Score Construction | |
| PGS Name | CC_Colorectal | 
| Development Method | |
| Name | Genome-wide significant variants | 
| Parameters | P < 5e-8, MAF > 1%, biallelic SNPs, LD-thin r2 > 0.3 | 
| Variants | |
| Original Genome Build | GRCh37 | 
| Number of Variants | 103 | 
| Effect Weight Type | NR | 
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000050 | 
| Citation (link to publication) | Graff RE et al. Nat Commun (2021) | 
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | 
|---|---|---|---|
| GWAS Catalog: GCST002919 Europe PMC: 25990418 | 17,556 individuals | European | NR | 
| GWAS Catalog: GCST000270 Europe PMC: 19011631 | 3,831 individuals | European | COGS, CoRGI | 
| GWAS Catalog: GCST000843 Europe PMC: 20972440 | 30,420 individuals | European | NR | 
| GWAS Catalog: GCST007856 Europe PMC: 30510241 | 120,184 individuals | European | NR | 
| GWAS Catalog: GCST007856 Europe PMC: 30510241 | 5,294 individuals | East Asian | NR | 
| GWAS Catalog: GCST002528 Europe PMC: 25023989 | 983 individuals | Other | CCFR, MECC | 
| GWAS Catalog: GCST006131 Europe PMC: 29917119 | 6,597 individuals | African American or Afro-Caribbean | NR | 
| GWAS Catalog: GCST006131 Europe PMC: 29917119 | 67,812 individuals | European | NR | 
| GWAS Catalog: GCST004895 Europe PMC: 28960316 | 15,783 individuals | European (Finnish) | NR | 
| GWAS Catalog: GCST000843 Europe PMC: 20972440 | 7,962 individuals | European | NR | 
| GWAS Catalog: GCST001544 Europe PMC: 22634755 | 17,780 individuals | European | COGS, CoRGI, NSCCG, SOCCS, VICTOR | 
| GWAS Catalog: GCST001787 Europe PMC: 23266556 | 27,809 individuals | European | NR | 
| GWAS Catalog: GCST002411 Europe PMC: 24737748 | 13,443 individuals | European | NR | 
| GWAS Catalog: GCST002512 Europe PMC: 2497848 | 1,281 individuals | European (Spain) | NR | 
| GWAS Catalog: GCST002528 Europe PMC: 25023989 | 2,976 individuals | European | NR | 
| GWAS Catalog: GCST003017 Europe PMC: 26151821 | 37,955 individuals | European | NR | 
| PGS Performance Metric ID (PPM) | PGS Sample Set ID (PSS) | Performance Source | Trait | PGS Effect Sizes (per SD change) | Classification Metrics | Other Metrics | Covariates Included in the Model | PGS Performance: Other Relevant Information | 
|---|---|---|---|---|---|---|---|---|
| PPM000194 | PSS000113| European Ancestry| 416,249 individuals | PGP000050 | Graff RE et al. Nat Commun (2021) | Reported Trait: Colorectal cancer | OR: 1.37 [1.33, 1.4] | — | — | Genotyping reagent kit (GERA cohort only), genotyping array (UK Biobank only), age, sex, 10 PCs. | Results from meta-analysis of GERA and UKB | 
| PPM002040 | PSS001013| European Ancestry| 393,723 individuals | PGP000186 | Kachuri L et al. Nat Commun (2020)|Ext. | Reported Trait: Incident colorectal cancer | HR: 1.32 [1.27, 1.37] | AUROC: 0.704 C-index: 0.704 (0.006) | — | Age at assessment, sex, family history of bowel cancer, genotyping array, PCs(1-15), wasit to hip ratio, cigarette pack years, frequency of processed meat intake (<1 per week vs. ≥1 per week), moderate and/or strenuous physical activity (days per week), alcohol intake | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. | 
| PPM017164 | PSS010144| European Ancestry| 2,150 individuals | PGP000443 | Byrne S et al. Int J Epidemiol (2023)|Ext. | Reported Trait: Colorectal cancer | HR: 1.36 [1.31, 1.42] | — | — | age at baseline, sex (where relevant), assessment centre, 40 principal components of ancestries (PCs), Townsend Index, education, birth location, income, lifestyle index, additional cancer-specific covariates | — | 
| PGS Sample Set ID (PSS) | Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information | 
|---|---|---|---|---|---|---|---|---|
| PSS000113 | Cancer diagnoses were obtained from reigstry data in GERA, and ICD-9/10 codes mapped to ICD-O-3 codes in UK Biobank. Cancers for this phenotype were classified using the following SEER site recode(s): 21041 - 21049, 21051, 21052, and 21060 | — | [, 
 46.0 % Male samples | Mean = 58.0 years | European | — | GERA, UKB | — | 
| PSS001013 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [ 
 | — | European | — | UKB | — | 
| PSS010144 | — | — | [ 
 | — | European | — | UKB | — |